Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature
- PMID: 31771337
- DOI: 10.1177/1060028019890886
Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature
Abstract
Objective: To review the use of antibiotic stewardship interventions in the adult oncology and hematopoietic cell transplantation (HCT) populations. Data Sources: A literature search of PubMed was performed from inception to October 31, 2019. The general search terms used were oncology, cancer, hematologic malignancy, antimicrobial stewardship, antibiotic stewardship, febrile neutropenia, neutropenic fever, de-escalation, discontinuation, prophylaxis, practice guidelines, clinical pathway, rapid diagnostics, Filmarray, Verigene, MALDI-TOF, antibiotic allergy, and antimicrobial resistance. Study Selection and Data Extraction: Relevant English-language studies describing interventions supported by the Infectious Diseases Society of America guidelines on "Implementing an Antibiotic Stewardship Program" were included. Data Synthesis: Antibiotic stewardship publications in the oncology population have increased in recent years. Studies have described the impact of stewardship interventions, including preauthorization, prospective audit and feedback, implementation of clinical pathways, de-escalation of empirical antibiotics for febrile neutropenia (FN) prior to neutrophil recovery, allergy assessments, and use of rapid diagnostic testing. Many of these interventions have been shown to decrease antibiotic use without increased negative consequences, such as affecting length of stay or mortality. Relevance to Patient Care and Clinical Practice: This review synthesizes available evidence for implementing antibiotic stewardship interventions, particularly de-escalation of antibiotics for FN and implementation of clinical pathways for FN and sepsis, in oncology patients and HCT recipients. Summary tables highlight studies and specific research needs for clinicians. Conclusions: Immunocompromised populations, including oncology patients, have often been excluded from stewardship studies. Antibiotic stewardship is effective in reducing antibiotic consumption and improving outcomes in this patient population, although more quality data are needed.
Keywords: antibiotic resistance; antibiotics; bone marrow transplantation; cancer; clinical pathways; febrile neutropenia; immunosuppression; infectious diseases; oncology.
Similar articles
-
Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipients.Transpl Infect Dis. 2019 Dec;21(6):e13175. doi: 10.1111/tid.13175. Epub 2019 Oct 1. Transpl Infect Dis. 2019. PMID: 31539459
-
Preadmission Penicillin Allergy Evaluation Before Hematopoietic Stem Cell Transplantation Optimizes Febrile Neutropenia Treatment and Inpatient Resource Utilization.Transplant Cell Ther. 2024 Nov;30(11):1112.e1-1112.e9. doi: 10.1016/j.jtct.2024.08.021. Epub 2024 Sep 4. Transplant Cell Ther. 2024. PMID: 39241913
-
Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship.Transpl Infect Dis. 2023 Nov;25 Suppl 1:e14094. doi: 10.1111/tid.14094. Epub 2023 Jul 7. Transpl Infect Dis. 2023. PMID: 37418600 Review.
-
Feasibility and applicability of antimicrobial stewardship in immunocompromised patients.Curr Opin Infect Dis. 2017 Aug;30(4):346-353. doi: 10.1097/QCO.0000000000000380. Curr Opin Infect Dis. 2017. PMID: 28542093 Review.
-
Antimicrobial stewardship in high-risk febrile neutropenia patients.Antimicrob Resist Infect Control. 2022 Mar 26;11(1):52. doi: 10.1186/s13756-022-01084-0. Antimicrob Resist Infect Control. 2022. PMID: 35346373 Free PMC article.
Cited by
-
Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation.Antibiotics (Basel). 2023 Jan 20;12(2):226. doi: 10.3390/antibiotics12020226. Antibiotics (Basel). 2023. PMID: 36830136 Free PMC article.
-
Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach.Transpl Infect Dis. 2021 Aug;23(4):e13689. doi: 10.1111/tid.13689. Epub 2021 Jul 30. Transpl Infect Dis. 2021. PMID: 34255395 Free PMC article.
-
Antimicrobial Stewardship on Patients with Neutropenia: A Narrative Review Commissioned by Microorganisms.Microorganisms. 2023 Apr 26;11(5):1127. doi: 10.3390/microorganisms11051127. Microorganisms. 2023. PMID: 37317101 Free PMC article. Review.
-
Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia.Antibiotics (Basel). 2024 Dec 28;14(1):13. doi: 10.3390/antibiotics14010013. Antibiotics (Basel). 2024. PMID: 39858299 Free PMC article.
-
Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population.J Adv Pract Oncol. 2022 Jan;13(1):61-69. doi: 10.6004/jadpro.2022.13.1.5. Epub 2022 Feb 1. J Adv Pract Oncol. 2022. PMID: 35173989 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous